A groundbreaking treatment targeting the RAS gene is moving into human trials. This innovative approach may treat various cancers while minimizing side effects, offering new hope for patients.
A groundbreaking study shows that taking a low dose of aspirin daily can significantly reduce the risk of colorectal cancer recurrence by 55% for patients with specific PI3K pathway mutations. Learn how this common pill could change lives!
